Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Elsevier Science Inc
2020
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/37566/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|